Company Profile

KDT LLC (AKA: Knudra Transgenics)
Profile last edited on: 12/14/2023      CAGE: 5RWB1      UEI: VL45N7PYHEW9

Business Identifier: Genome Editing Technology
Year Founded
2009
First Award
2016
Latest Award
2019
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5201 South Green Street Suite 140
Murray, UT 84123
   (385) 202-3854
   info@knudra.com/contact/
   www.knudra.com
Location: Single
Congr. District: 04
County: Salt Lake

Public Profile

Knudra Transgenics is organzized around supplying researchers and private entities custom-built transgenics. Starting first in C elegans then expanding into zebrafish and soon to be mice, Knudra has gained the experience to efficiently get clients the transgenics they need. Using the latest advances in genome engineering to build powerful platforms of medical discovery and technology licensed from the University of Utah to turn a small-model organisms into a platform for biomedical discovery, Knudra Transgenics creates innovative biological tools for discovery in life sciences. In TavaServ, Knudra Transgenics sells a custom manufacturing service to make bioengineered nematodes for its researcher clients. Using a proprietary bioengineering technology, genes areinserted into the nematode genome. The result is a sophisticated expression system for exploring biological pathways, studying disease biology and discovering sample toxicity

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2019 2 NIH $1,724,999
Project Title: A Fluorescent Reporter Detecting Precise Homologous Recombination Transgenesis Activity

Key People / Management

  Trisha Brock -- CEO

  Chris Hopkins -- CSO and Founder

  Thomas Marshall -- Molecular Biology Specialist

  Stelian Pop -- Injection Specialist

  Zach Stevenson -- Mutagenesis Specialist

Company News